GAD2 and type 1 diabetes mellitus: Specifically, these assays may allow detection and quantification of GAD65 and GAD65-GADA complexes in prediabetic subjects18 or in patients recently diagnosed with T1D, in order to estimate the loss of beta cells once insulin therapy has been initiated19.